Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, Large B-Cell, Diffuse | 12 | 2024 | 1405 | 2.340 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 15 | 2024 | 1640 | 1.560 |
Why?
|
Lymphoma, Follicular | 3 | 2022 | 457 | 1.020 |
Why?
|
Antibodies, Bispecific | 2 | 2022 | 196 | 0.830 |
Why?
|
Immunotherapy, Adoptive | 11 | 2024 | 1468 | 0.810 |
Why?
|
Antigens, CD19 | 7 | 2023 | 424 | 0.740 |
Why?
|
Mucin-1 | 6 | 2017 | 537 | 0.570 |
Why?
|
Antineoplastic Agents | 9 | 2022 | 13630 | 0.570 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2023 | 2549 | 0.570 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2015 | 694 | 0.480 |
Why?
|
Yttrium Radioisotopes | 1 | 2015 | 107 | 0.450 |
Why?
|
Vidarabine | 4 | 2024 | 336 | 0.440 |
Why?
|
Purines | 4 | 2021 | 609 | 0.420 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 13 | 2024 | 11732 | 0.400 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 3 | 2020 | 269 | 0.370 |
Why?
|
Immunoglobulin A | 2 | 2012 | 978 | 0.360 |
Why?
|
Antibodies, Neoplasm | 1 | 2011 | 282 | 0.330 |
Why?
|
Hematopoietic Stem Cell Transplantation | 7 | 2024 | 5667 | 0.320 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 2 | 2012 | 242 | 0.310 |
Why?
|
B-Lymphocytes | 2 | 2022 | 4744 | 0.310 |
Why?
|
Dendritic Cells | 3 | 2017 | 2726 | 0.300 |
Why?
|
Graft vs Host Disease | 4 | 2024 | 3026 | 0.280 |
Why?
|
Immunoglobulin M | 1 | 2012 | 1527 | 0.280 |
Why?
|
T-Lymphocytes | 9 | 2023 | 10203 | 0.280 |
Why?
|
Quinazolinones | 2 | 2019 | 221 | 0.260 |
Why?
|
Adenine | 5 | 2024 | 986 | 0.260 |
Why?
|
Thrombocytopenia | 4 | 2022 | 1182 | 0.250 |
Why?
|
Cyclophosphamide | 5 | 2024 | 2219 | 0.240 |
Why?
|
Lymphoma, B-Cell | 2 | 2022 | 938 | 0.240 |
Why?
|
Vaccination | 2 | 2016 | 3368 | 0.230 |
Why?
|
Remission Induction | 4 | 2021 | 2392 | 0.230 |
Why?
|
Multiple Myeloma | 4 | 2017 | 5145 | 0.230 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2017 | 212 | 0.230 |
Why?
|
Chromosomes, Human, Pair 17 | 2 | 2018 | 418 | 0.220 |
Why?
|
Antigens, CD34 | 2 | 2024 | 655 | 0.220 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2813 | 0.220 |
Why?
|
Isoquinolines | 2 | 2021 | 352 | 0.210 |
Why?
|
Piperidines | 5 | 2024 | 1656 | 0.210 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2022 | 1372 | 0.210 |
Why?
|
Pyrazoles | 5 | 2020 | 2010 | 0.200 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2023 | 3609 | 0.200 |
Why?
|
Antibodies, Monoclonal | 4 | 2016 | 9185 | 0.200 |
Why?
|
Hepatic Veno-Occlusive Disease | 1 | 2023 | 220 | 0.190 |
Why?
|
Neutropenia | 2 | 2024 | 885 | 0.190 |
Why?
|
Cryptosporidiosis | 1 | 2021 | 52 | 0.190 |
Why?
|
Chromosome Deletion | 2 | 2018 | 1386 | 0.180 |
Why?
|
Pyrimidines | 4 | 2020 | 3026 | 0.170 |
Why?
|
Sulfonamides | 2 | 2021 | 1977 | 0.170 |
Why?
|
Leukemia, Prolymphocytic, B-Cell | 1 | 2019 | 1 | 0.170 |
Why?
|
Antigens, Neoplasm | 3 | 2017 | 1984 | 0.160 |
Why?
|
Cancer Vaccines | 3 | 2017 | 1038 | 0.160 |
Why?
|
Vinblastine | 1 | 2019 | 488 | 0.150 |
Why?
|
Humans | 54 | 2024 | 761098 | 0.140 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2019 | 147 | 0.140 |
Why?
|
Transplantation, Homologous | 5 | 2024 | 4822 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2017 | 5300 | 0.140 |
Why?
|
Doxorubicin | 2 | 2024 | 2224 | 0.140 |
Why?
|
Dacarbazine | 1 | 2019 | 559 | 0.130 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2018 | 237 | 0.130 |
Why?
|
Quinoxalines | 1 | 2018 | 296 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2024 | 9278 | 0.130 |
Why?
|
Signal Transduction | 3 | 2017 | 23415 | 0.130 |
Why?
|
Benzamides | 1 | 2021 | 1370 | 0.130 |
Why?
|
Azacitidine | 1 | 2017 | 336 | 0.130 |
Why?
|
Pyrazines | 1 | 2021 | 1202 | 0.130 |
Why?
|
Radioimmunotherapy | 1 | 2015 | 91 | 0.120 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2017 | 544 | 0.120 |
Why?
|
Sequence Deletion | 1 | 2018 | 1487 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 3 | 2019 | 5662 | 0.110 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2017 | 651 | 0.110 |
Why?
|
Autoimmunity | 1 | 2021 | 1354 | 0.110 |
Why?
|
Transplantation, Autologous | 3 | 2023 | 2112 | 0.110 |
Why?
|
Aged | 18 | 2024 | 169266 | 0.110 |
Why?
|
Cell Proliferation | 4 | 2017 | 10421 | 0.100 |
Why?
|
Cell Communication | 2 | 2017 | 1650 | 0.100 |
Why?
|
Treatment Failure | 2 | 2024 | 2643 | 0.100 |
Why?
|
Aged, 80 and over | 11 | 2024 | 58946 | 0.100 |
Why?
|
Apoptosis | 4 | 2017 | 9478 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1895 | 0.100 |
Why?
|
Peptides | 2 | 2015 | 4353 | 0.100 |
Why?
|
Hodgkin Disease | 1 | 2019 | 1378 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2019 | 2914 | 0.090 |
Why?
|
Stromal Cells | 1 | 2017 | 1329 | 0.090 |
Why?
|
Bone Marrow | 2 | 2020 | 2911 | 0.090 |
Why?
|
Middle Aged | 19 | 2024 | 220835 | 0.090 |
Why?
|
Clinical Trials as Topic | 3 | 2017 | 8000 | 0.080 |
Why?
|
Hemorrhage | 2 | 2020 | 3422 | 0.080 |
Why?
|
Platelet Count | 1 | 2012 | 782 | 0.080 |
Why?
|
Coculture Techniques | 3 | 2017 | 1334 | 0.080 |
Why?
|
Receptors, Interleukin-6 | 1 | 2010 | 224 | 0.080 |
Why?
|
Oxidative Stress | 2 | 2017 | 3114 | 0.080 |
Why?
|
Standard of Care | 2 | 2022 | 550 | 0.080 |
Why?
|
Recurrence | 3 | 2022 | 8456 | 0.080 |
Why?
|
Anemia, Aplastic | 1 | 2010 | 230 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2015 | 1264 | 0.080 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2017 | 2426 | 0.080 |
Why?
|
Adult | 14 | 2024 | 221083 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2020 | 4574 | 0.070 |
Why?
|
Treatment Outcome | 11 | 2024 | 64670 | 0.070 |
Why?
|
Up-Regulation | 2 | 2017 | 4111 | 0.070 |
Why?
|
Thrombopoiesis | 1 | 2008 | 164 | 0.070 |
Why?
|
Antigen Presentation | 1 | 2012 | 1251 | 0.070 |
Why?
|
Immunoglobulin Isotypes | 1 | 1987 | 158 | 0.070 |
Why?
|
Thalidomide | 1 | 2012 | 885 | 0.070 |
Why?
|
Rheumatoid Factor | 1 | 1987 | 184 | 0.070 |
Why?
|
Immunity, Cellular | 1 | 2012 | 1553 | 0.070 |
Why?
|
Lymphocyte Activation | 4 | 2021 | 5478 | 0.070 |
Why?
|
Female | 22 | 2024 | 392458 | 0.070 |
Why?
|
Survival Analysis | 4 | 2020 | 10083 | 0.060 |
Why?
|
Mice, SCID | 3 | 2016 | 2621 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2013 | 1348 | 0.060 |
Why?
|
Male | 21 | 2024 | 360675 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4189 | 0.060 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2019 | 646 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2024 | 39121 | 0.060 |
Why?
|
Europe | 1 | 2021 | 3422 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2020 | 11118 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6817 | 0.060 |
Why?
|
MicroRNAs | 2 | 2017 | 3758 | 0.060 |
Why?
|
Anticoagulants | 1 | 2020 | 4795 | 0.060 |
Why?
|
Neoplasm, Residual | 2 | 2021 | 1008 | 0.060 |
Why?
|
Animals | 10 | 2020 | 168083 | 0.060 |
Why?
|
Medicare | 1 | 2022 | 6775 | 0.060 |
Why?
|
Cell Line, Tumor | 5 | 2017 | 16947 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2017 | 3591 | 0.050 |
Why?
|
Young Adult | 7 | 2024 | 59199 | 0.050 |
Why?
|
Bone Resorption | 1 | 1987 | 723 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2016 | 3092 | 0.050 |
Why?
|
Polydeoxyribonucleotides | 1 | 2023 | 136 | 0.050 |
Why?
|
Prognosis | 4 | 2020 | 29672 | 0.050 |
Why?
|
Drug Administration Schedule | 2 | 2021 | 4849 | 0.050 |
Why?
|
United States | 3 | 2023 | 72337 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2010 | 1600 | 0.050 |
Why?
|
Vincristine | 1 | 2024 | 1036 | 0.050 |
Why?
|
Intestines | 1 | 2010 | 1908 | 0.050 |
Why?
|
Antigens, CD20 | 1 | 2022 | 199 | 0.050 |
Why?
|
Immunoenzyme Techniques | 2 | 2015 | 1703 | 0.050 |
Why?
|
Immunologic Factors | 1 | 2010 | 1589 | 0.050 |
Why?
|
Mutation | 3 | 2020 | 30006 | 0.050 |
Why?
|
Survival Rate | 1 | 2015 | 12727 | 0.040 |
Why?
|
Leukapheresis | 1 | 2020 | 134 | 0.040 |
Why?
|
Clone Cells | 1 | 2023 | 1667 | 0.040 |
Why?
|
Mice, Inbred NOD | 2 | 2015 | 1822 | 0.040 |
Why?
|
Toll-Like Receptor 9 | 1 | 2020 | 193 | 0.040 |
Why?
|
Mice | 8 | 2020 | 81324 | 0.040 |
Why?
|
Safety-Based Drug Withdrawals | 1 | 2019 | 36 | 0.040 |
Why?
|
Chronic Disease | 3 | 2023 | 9317 | 0.040 |
Why?
|
Dioxygenases | 1 | 2020 | 345 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6585 | 0.040 |
Why?
|
Reactive Oxygen Species | 2 | 2017 | 2138 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 929 | 0.040 |
Why?
|
Adolescent | 5 | 2024 | 88271 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2020 | 1750 | 0.040 |
Why?
|
Cross-Priming | 1 | 2017 | 76 | 0.040 |
Why?
|
Perforin | 1 | 2017 | 166 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4565 | 0.030 |
Why?
|
Methylprednisolone | 1 | 2018 | 386 | 0.030 |
Why?
|
Blotting, Western | 2 | 2015 | 5033 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2017 | 286 | 0.030 |
Why?
|
Cisplatin | 1 | 2022 | 1651 | 0.030 |
Why?
|
Germ Cells | 1 | 2020 | 632 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2021 | 858 | 0.030 |
Why?
|
Safety | 1 | 2020 | 1151 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5809 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2020 | 2217 | 0.030 |
Why?
|
Receptors, Antigen | 1 | 2015 | 51 | 0.030 |
Why?
|
Ribonuclease III | 1 | 2017 | 267 | 0.030 |
Why?
|
Hematologic Diseases | 1 | 2019 | 496 | 0.030 |
Why?
|
Isoantigens | 1 | 2017 | 559 | 0.030 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2016 | 302 | 0.030 |
Why?
|
Dexamethasone | 1 | 2022 | 1945 | 0.030 |
Why?
|
Diarrhea | 1 | 2021 | 1318 | 0.030 |
Why?
|
Cytokines | 2 | 2021 | 7386 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1837 | 0.030 |
Why?
|
NADP | 1 | 2015 | 227 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2012 | 15845 | 0.030 |
Why?
|
Hepatitis, Autoimmune | 1 | 2016 | 172 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2017 | 1351 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2015 | 5870 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3307 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2017 | 559 | 0.030 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 412 | 0.030 |
Why?
|
Prednisone | 1 | 2018 | 1565 | 0.030 |
Why?
|
Immunomodulation | 1 | 2017 | 549 | 0.030 |
Why?
|
Incidence | 1 | 2021 | 21357 | 0.030 |
Why?
|
Glutathione | 1 | 2015 | 581 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 872 | 0.030 |
Why?
|
Drug Synergism | 1 | 2016 | 1756 | 0.020 |
Why?
|
Age Factors | 2 | 2020 | 18385 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 1987 | 3754 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20600 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 987 | 0.020 |
Why?
|
Immune System | 1 | 2016 | 792 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 4014 | 0.020 |
Why?
|
Biological Products | 1 | 2020 | 913 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2227 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2017 | 1751 | 0.020 |
Why?
|
Anemia | 1 | 2020 | 1504 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1611 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 26068 | 0.020 |
Why?
|
Gene Silencing | 1 | 2017 | 1496 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 1837 | 0.020 |
Why?
|
Infant | 1 | 2012 | 36164 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1138 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1663 | 0.020 |
Why?
|
Neoplasms | 2 | 2015 | 22125 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2015 | 12743 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 42217 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2017 | 3155 | 0.020 |
Why?
|
Immunoblotting | 1 | 2012 | 1644 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9324 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2018 | 2160 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2013 | 1867 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2023 | 12467 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4510 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2017 | 11505 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4372 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2015 | 6123 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2013 | 2508 | 0.020 |
Why?
|
Benzoates | 1 | 2008 | 211 | 0.020 |
Why?
|
Hydrazines | 1 | 2008 | 222 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8519 | 0.020 |
Why?
|
Thrombopoietin | 1 | 2008 | 226 | 0.020 |
Why?
|
Arthrography | 1 | 1987 | 150 | 0.020 |
Why?
|
Cohort Studies | 2 | 2018 | 41486 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2870 | 0.020 |
Why?
|
Receptors, Fc | 1 | 2008 | 536 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2017 | 3869 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2024 | 80673 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2012 | 1803 | 0.010 |
Why?
|
Gene Expression | 1 | 2017 | 7567 | 0.010 |
Why?
|
Child | 1 | 2012 | 80134 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9566 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2243 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10758 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8529 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 13362 | 0.010 |
Why?
|
Liver | 1 | 2016 | 7513 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2008 | 3725 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 39953 | 0.010 |
Why?
|
Biopsy | 1 | 2010 | 6781 | 0.010 |
Why?
|
Hepatitis C | 1 | 2008 | 1579 | 0.010 |
Why?
|
Blood Platelets | 1 | 2008 | 2477 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22157 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11856 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2008 | 4933 | 0.010 |
Why?
|